Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Headway is an app that offers the best self-development books.Find out how it saves you time and helps you achieve your goals ...

Boost your science skills with top science tuition in Singapore. Expert coaching, exam strategies, and interactive learning ...